High pre‐treatment CD8+ T cell polyfunctional strength index (PSI) showed a trend toward association with early treatment response and deeper tumor shrinkage, while CD8+ PSI decreased post‐therapy in responders, although not significantly. Here, CD8A is linked to neoplasm.